Last updated on November 2019

A Study of Durvalumab or Tremelimumab Monotherapy or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma


Find a site near you

Start Over

Research Site

Sha Tin, Hong Kong
  Connect »

Research Site

Hong Kong, Hong Kong
5.77miles
  Connect »